Clinical Significance of Heterozygosity for Mutations of the SLC12A3 Gene Coding for the Thiazide Sensitive Na-Cl Cotransporter
Clinical trial NCT02035046 · COMPLETED
Trial details
- NCT number
- NCT02035046
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2016-09-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.